paperKB
coga / coga-kb
Help
Sign in

Chunk #59 — 5. Procedures for evaluating pharmacological treatments targeting alcohol abuse and dependence — 5.4. Relapse of ethanol drinking in the home-cage

Source
Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.
Embedded
yes

Text

Alcohol abuse and dependence are considered chronic relapsing disorders, such that 60–80 percent of abstinent alcoholics will relapse during their lifetime (Barrick and Connors, 2002; Chiauzzi, 1991; Jaffe, 2002; Weiss et al., 2001). Thus, an animal model of alcoholism ought to demonstrate this feature of the clinical picture as well (McBride and Li, 1998). Although a number of criteria for relapse have been put forth (Barrick and Connors, 2002; Chiauzzi, 1991; Jaffe, 2002; Weiss et al., 2001), the primary criterion holds that a return to levels of ethanol consumption equal to or greater than that observed prior to abstinence constitutes a relapse. As discussed by Rodd et al. (2004b), the ADE is one and probably the most often used measure of ethanol relapse-drinking behavior in rats. The ADE is defined as a temporary increase in the ratio of alcohol/total fluid intake and/or voluntary intake of ethanol solutions over baseline (prior to the deprivation period) levels when ethanol is reinstated following a period of alcohol deprivation (Sinclair and Senter, 1967). The aripiprazole study, mentioned above, also examined the drug’s effects on